Background
The Claimant sued the Respondent herein vide a Statement of Claim dated 5th January, 2026 and sought the following reliefs:-
Paragraph 1 →Included with active membership. View daily and monthly plans · Sign in
The Court allowed the claimant’s Notice of Motion dated 17 February 2026. Pending determination of the suit, it restrained the respondent and those acting for it from using, presenting, attributing, associating, or representing the claimant’s name, title, designation, or credentials in relation to the GLOPID-R grant project. Costs of the application were ordered to abide the outcome of the suit, which was to be fast-tracked for hearing.
17. Consequently, and having considered written submissions filed on behalf of both parties, the Notice of Motion dated 17th February, 2026 is hereby allowed in the following terms:-
Paragraph 17 →
(a) Pending hearing and determination of the suit herein, the Respondent, its agents, servants, employees or any other person acting on its behalf or under its authority, is hereby restrained from using, presenting, attributing, associating or representing the Claimant/Applicant’s name, title, designation or credentials in any form whatsoever in relation to the GLOPID-R grant project to any person or donor.
Passage 66 →
(b) Costs of the application will abide the outcome of the suit herein.
Passage 67 →
Held. Decided. The injunction was granted pending determination of the suit. The Court found that the claimant had an arguable case with a probability of success, faced irreparable reputational and professional injury if the conduct continued or recurred, and that the balance of convenience favoured her. The respondent would suffer no prejudice because the claimant was no longer its employee and it said it had notified donors and stakeholders of her exit and replacement.
Ratio. Interlocutory injunctive relief was warranted where the applicant demonstrated an arguable case with a probability of success, irreparable injury absent relief, and a balance of convenience in her favour. On the material before the Court, continued presentation of the claimant as technical lead for work she did not control risked irreparable professional and reputational harm, whereas restraint caused the respondent no demonstrated prejudice.
Issue
16. I am satisfied that the Claimant has demonstrated that she has an arguable case with a probability of success, that she stands to suffer an irreparable damage/injury unless the injunctive order sought is issued, and that the balance of convenience tilts in her favour.
Paragraph 16 →
Held
17. Consequently, and having considered written submissions filed on behalf of both parties, the Notice of Motion dated 17th February, 2026 is hereby allowed in the following terms:-
Paragraph 17 →
(a) Pending hearing and determination of the suit herein, the Respondent, its agents, servants, employees or any other person acting on its behalf or under its authority, is hereby restrained from using, presenting, attributing, associating or representing the Claimant/Applicant’s name, title, designation or credentials in any form whatsoever in relation to the GLOPID-R grant project to any person or donor.
Passage 66 →
Ratio
15. If the interlocutory injunctive order sought is granted, the Respondent will not suffer any prejudice as the Claimant is no longer its employee, and, according to it, it has already notified its donors and stakeholders of the Claimant’s exit, and of its new Technical Lead. Conversely, the Claimant will suffer an irreparable damage if the Respondent continues with or repeats the acts complained of by the Claimant.
Paragraph 15 →
16. I am satisfied that the Claimant has demonstrated that she has an arguable case with a probability of success, that she stands to suffer an irreparable damage/injury unless the injunctive order sought is issued, and that the balance of convenience tilts in her favour.
Paragraph 16 →
Selected passages from the judgment. Follow each paragraph link to read the full context.
The Claimant sued the Respondent herein vide a Statement of Claim dated 5th January, 2026 and sought the following reliefs:-
Paragraph 1 →I am satisfied that the Claimant has demonstrated that she has an arguable case with a probability of success, that she stands to suffer an irreparable damage/injury unless the injunctive order sought is issued, and that the balance of convenience tilts in her favour.
Paragraph 16 →Whether the claimant satisfied the requirements for an interlocutory injunction restraining IAVI Africa Limited from using, presenting, attributing, associating or representing her name, title, designation or credentials in relation to the GLOPID-R grant…
Esther Njoki Mungai was employed as Senior Director, Global Access. She deponed that IAVI Africa Limited had nominated her as Technical Lead for the GLOPID-R proposal, but excluded her from drafting, review and decisions while she was on certified sick leave…
Get the complete brief with membership →REPUBLIC OF KENYA
IN THE EMPLOYMENT AND LABOUR RELATIONS COURT AT NAIROBI
CAUSE NO. E122 OF 2026
(Before Hon. Lady Justice Agnes Kitiku Nzei)
ESTHER NJOKI MUNGAI CLAIMANT
VERSUS
IAVI AFRICA LIMITED ..RESPONDENT
RULING
1. The Claimant sued the Respondent herein vide a Statement of Claim dated 5th January, 2026 and sought the following reliefs:-
(a) A declaration that the Claimant was constructively and unfairly dismissed.
(b) General damages for unfair termination equivalent to the Claimant’s twelve (12) months’ salary; totalling to Kshs.14,500,000/=.
(c) Aggravated damages arising from the high-handed, humiliating and malicious conduct, public disparagement of the Claimant’s competence during her sick leave, and the ensuing reputational harm within the global health sector, and the Claimant’s emotional distress and health impacts; as well as future earnings.
(d) Certificate of service.
(e) Immediate cease and desist from unauthorised use of the Claimant’s name and credentials, with a written confirmation that the Respondent has ceased all use of the Claimant’s name and professional credentials in connection with the GLOPID-R Proposal or any related content and activities.
(f) Written indemnity against Third Party claims, present or future, and/or reputational exposure arising from the unauthorised use of the Claimant’s name and credentials in donor submissions, partner communications, or external representations in connection with the GLOPID-R Proposal or any related activities.
(g) Costs of the suit.
(h) Interest on (b), (c) and (g) above at Court rates.
(i) Any other or further relief that the Court may deem just and fit.
2. On 20th February, 2026, the Claimant filed a Notice of Motion dated 17th February, 2026 seeking the following Orders:-
(a) That the application be certified urgent, and be heard ex-parte in the first instance.
(b) That pending hearing and determination of the application, a temporal injunction be granted restraining the Respondent whether by itself, its officers, agents, servants, employees, or any person acting under its authority, from using, presenting, attributing, associating, or representing the applicant’s name, title, designation, or credentials in any form whatsoever in relation to the GLOPID-R grant, including but not limited to:-
(i) Donor communications.
(ii) Submissions, clarifications and technical correspondence.
(iii) Portal records and grant documentation.
(iv) Internal and external reports; and
(v) Project implementation representations.
(c) That pending hearing and determination of the suit, a temporal injunction be granted restraining the Respondent, whether by itself, its officers, agents, servants, employees, or any person acting under its authority, from using, presenting, attributing, associating, or representing the applicant’s name, title, designation, or credentials in any form whatsoever in relation to the GLOPID-R grant, including but not limited to:-
(i) Donor communications.
(ii) Submissions, clarifications and technical correspondence.
(iii) Portal records and grant documentation.
(iv) Internal and external reports; and
(v) Project implementation representations.
(d) That the application be heard inter-partes on such dates and at such time as the Court may direct.
(e) That costs of the application be awarded to the Claimant/Applicant.
3. The application is based on the Claimant’s supporting affidavit sworn on 17th February, 2026. It is deponed in the said supporting affidavit, inter-alia:-
(a) that at all material times, the Claimant/Applicant (the applicant) was employed by the Respondent as Senior Director, Global Access, a senior donor financing role requiring personal accountability, professional credibility and technical oversight.
(b) that during the subsistence of the Applicant’s employment, the Respondent nominated and presented her as the Technical Lead for the GLOPID-R Grant Proposal, thereby expressly holding her out to the donor and external stakeholders as personally responsible for the technical content, integrity and delivery of the proposal.
(c) that on or about 10th November, 2025 to 19th November, 2025, the Applicant fell ill, and was placed on certified sick leave from 10th November, 2025 to 19th November, 2025, which information, together with the relevant medical advice, the Applicant duly communicated to the Respondent.
(d) that while on sick leave, and thereafter on approved annual leave, the Applicant was effectively excluded from drafting, review and decision making on the grant proposal, yet the Respondent continued to present and to hold her out to the donor as the Technical Lead for GLOPID-R Grant.
(e) that upon discovering the foregoing misrepresentation and its likely consequences to her career, the Applicant expressly and unequivocally requested the Respondent to remove her name from the GLOPID-R Proposal to protect her professional standing, but the Respondent refused and/or deliberately delayed complying with the request, and continued to present and to submit the proposal while holding the Applicant out as the Technical Lead.
(f) that the Respondent’s actions demonstrate an arguable and enforceable violation of the Claimant/Applicant’s contractual, professional and reputational rights, thereby establishing a prima facie case with a high probability of success.
(g) that as a direct consequence of the Respondent’s misrepresentation, the donor contacted the Applicant directly seeking technical clarifications and accountability, exposing the Applicant to immediate professional, ethical and reputational risk.
(h) that the Applicant is unable to vouch for, verify or defend the contents, timelines, or representations made in the proposal; yet any deficiencies or adverse outcomes will be personally attributed to her as the named Technical Lead.
(i) that the global health funding community is small, interconnected, and reputation sensitive, and credibility once questioned cannot be restored through monetary compensation.
(j) that should the donor discover that the Claimant was not substantively involved despite having been presented as Technical Lead, her professional integrity would be permanently impaired, with long term consequences on her career, future donor engagements, and standing in the sector.
(k) that the Applicant suffered, and continues to suffer mental anguish, stress, embarrassment and professional stress, which injuries are inherently non-pecuniary; and that the balance of convenience overwhelmingly favours the grant of the injunctive relief sought.
4. Documents annexed to the supporting affidavit include copies of the Claimant’s employment agreement, medical certificate (sick-off sheet) dated 10th November, 2025 and donor correspondence (email) dated 26th November, 2025.
5. The application is opposed by the Respondent vide a detailed replying affidavit of Shelly Malhorta sworn on 25th March, 2026. I have noted the depositions made in the said replying affidavit and the documents thereto annexed. I have in particular noted the deposition that the Claimant had not been held out as personally responsible for the GLOPID-R Proposal. I have also noted that the letter and/or communication appointing the Claimant as the Technical Lead of the mentioned proposal and terms of the appointment was not placed before the Court.
6. The application was presented to the Court under a Certificate of Urgency on 20th February, 2026, and the Court directed that the same be served. On 12th March, 2026, Counsel for the Respondent pleaded with the Court not to issue an interim order, stating that the application had been overtaken by events as the proposal (in issue) had already been presented to the donor, and that what was being awaited was the outcome. That the Respondent had already written to the donor and informed them that the Claimant was not part of the proposal. Counsel requested for time (upto the following morning) for parties to discuss the matter, and possibly come up with a consent, which time the Court granted. No consent was reached, though. The Court issued directions on disposal of the application, and further issued an interim restraining order in favour of the Claimant/Applicant, having been satisfied that such orders were deserved. The Respondent sought leave to appeal, and leave was granted.
7. Parties filed written submissions for and against the application pursuant to the Court’s directions in that regard.
8. In his written submissions, Counsel for the Claimant/Applicant referred the Court to the celebrated case of Giella – vs – Cassman Brown & Co. Ltd [1973] E.A 358 and urged the Court to allow the application, as it was undisputed that while on sick leave and annual leave which the Respondent had approved, the Claimant/Applicant was excluded from the drafting, review of, and decision making relating to the aforementioned proposal, and that despite the exclusion, the Claimant continued to submit and to maintain the proposal bearing the Applicant’s name, thereby recklessly attributing technical responsibility to the Claimant, for work she neither controlled nor verified. He argued that a prima facie case had been established.
9. On irreparable injury, it was submitted that the injury complained of by the Applicant could not be atoned for in monetary compensation, and that on the balance of convenience, the Court should weigh which party would suffer greater harm by granting or refusing the injunction.
10. In the case of Mrao Ltd – vs – First American Bank of Kenya & 2 Others [2003] KECA 175 (KLR), the Court of Appeal (Bosire, JA) stated as follows:-
“17. So what is a prima facie case? I would say that in civil cases, it is a case in which on the material presented to the Court, a tribunal properly directing itself will conclude that there exists a right which has apparently been infringed by the opposite party as to call for an explanation or rebuttal from the latter”.
11. In the present case, the fact of the presentation of a proposal, bearing the Claimant/Applicant’s name and credentials and description of her therein as the Technical Lead, as pleaded and deponed by the Claimant/Applicant, is not principally denied by the Respondent. Indeed, the Court was on 13th March, 2026 informed by Counsel for the parties herein that the Respondent had written to their donor informing them that their new Technical Lead was one Dr. Chinyenze. The injury complained of by the Claimant is reputational and possible damage to her profession and career; should the Respondent continue using and presenting her name and credential to third parties regarding proposals/projects that she was not involved in and had no control over.
12. Indeed, it is submitted as follows in the written submissions filed on behalf of the Respondent:-
“6. Between 10th and 19th November, 2025, while the Claimant was still working on the GLOPID-R Proposal application, she went on sick leave, leaving the rest of the team she was working with to finalise on the GLOPID-R Proposal process in her temporary absence. During her absence, the Claimant remained the Technical Lead on the GLOPID-R application as a matter of course and in recognition of the work she had already contributed to the GLOPID-R Proposal.
7. The Claimant wilfully and voluntarily resigned on 14th January, 2026, two months after the GLOPID-R Proposal had been submitted; and on 20th January, 2026 demanded that the Respondent ceases to represent her as the team lead and member with respect to the GLOPID-R Proposal.
8. Accordingly, the Respondent issued a notice to the GLOPID-R Proposal donors and stakeholders informing them of the Claimant’s exit from the Respondent and of the Respondent’s new lead for the GLOPID-R application and implementation, which notice was duly acknowledged. (See pages 1 to 3, pages 8 and 11 of the Exhibit SM-1 annexed to the Replying Affidavit).
9. The Claimant’s name is no longer being held out in any form whatsoever by the Respondent, its officers, agents, servants, employees, or any person acting under its authority in relation to GLOPID-R Proposal. All donor communications and relevant correspondences are duly updated of the Claimant’s exit and of her replacement at the Respondent”.
13. From all the foregoing, it is clear that the Claimant/Applicant is no longer an employee of the Respondent. It is also admitted by the Respondent that the GLOPID-R Proposal application, of which the Claimant was the Technical Lead at the Respondent, was work in progress when the Claimant went on sick off and subsequently on annual leave. The Court has not, however, been told by the Respondent how much work had been done on the proposal as on 10th November, 2025, how much work was put in/done by others in the Claimant’s absence, who those others were, whether they were appropriately qualified, and whether they worked in consultation with the Claimant as the Technical Lead.
14. Indeed, it has not been demonstrated when exactly the GLOPID-R Proposal was submitted to the donors, was it before or after the Claimant’s sick-off, annual leave and resignation? All that the Respondent has stated is that the Claimant had been replaced with another Technical Lead, and that the project’s donors and stakeholders had been informed by the Respondent. It is clear from the material presented before this Court that the Claimant was replaced as the Technical Lead after submission of the proposal.
15. If the interlocutory injunctive order sought is granted, the Respondent will not suffer any prejudice as the Claimant is no longer its employee, and, according to it, it has already notified its donors and stakeholders of the Claimant’s exit, and of its new Technical Lead. Conversely, the Claimant will suffer an irreparable damage if the Respondent continues with or repeats the acts complained of by the Claimant.
16. I am satisfied that the Claimant has demonstrated that she has an arguable case with a probability of success, that she stands to suffer an irreparable damage/injury unless the injunctive order sought is issued, and that the balance of convenience tilts in her favour.
17. Consequently, and having considered written submissions filed on behalf of both parties, the Notice of Motion dated 17th February, 2026 is hereby allowed in the following terms:-
(a) Pending hearing and determination of the suit herein, the Respondent, its agents, servants, employees or any other person acting on its behalf or under its authority, is hereby restrained from using, presenting, attributing, associating or representing the Claimant/Applicant’s name, title, designation or credentials in any form whatsoever in relation to the GLOPID-R grant project to any person or donor.
(b) Costs of the application will abide the outcome of the suit herein.
18. The suit herein will be fast-tracked, and will be fixed for hearing.
19. Orders accordingly.
DATED, SIGNED AND DELIVERED AT NAIROBI THIS
9TH DAY OF OCTOBER 2026
AGNES KITIKU NZEI
JUDGE
ORDER
This Ruling has been delivered via Microsoft Teams Online Platform. A signed copy will be availed to each party upon payment of the applicable Court fees.
AGNES KITIKU NZEI
JUDGE
Appearance:
Mr. Kiamba for the Claimant
Miss Muthiani for the Respondent